ICAD
Price
$1.69
Change
-$0.11 (-6.15%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
VMD
Price
$8.13
Change
-$0.46 (-5.36%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
Ad is loading...

ICAD vs VMD

Header iconICAD vs VMD Comparison
Open Charts ICAD vs VMDBanner chart's image
iCAD
Price$1.69
Change-$0.11 (-6.15%)
Volume$2.64K
CapitalizationN/A
Viemed Healthcare
Price$8.13
Change-$0.46 (-5.36%)
Volume$2.19K
CapitalizationN/A
ICAD vs VMD Comparison Chart
Loading...
ICAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICAD vs. VMD commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICAD is a Hold and VMD is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ICAD: $1.79 vs. VMD: $8.59)
Brand notoriety: ICAD and VMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICAD: 63% vs. VMD: 114%
Market capitalization -- ICAD: $42.43M vs. VMD: $363.54M
ICAD [@Medical Specialties] is valued at $42.43M. VMD’s [@Medical Specialties] market capitalization is $363.54M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICAD’s FA Score shows that 0 FA rating(s) are green whileVMD’s FA Score has 0 green FA rating(s).

  • ICAD’s FA Score: 0 green, 5 red.
  • VMD’s FA Score: 0 green, 5 red.
According to our system of comparison, ICAD is a better buy in the long-term than VMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICAD’s TA Score shows that 7 TA indicator(s) are bullish while VMD’s TA Score has 3 bullish TA indicator(s).

  • ICAD’s TA Score: 7 bullish, 3 bearish.
  • VMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ICAD is a better buy in the short-term than VMD.

Price Growth

ICAD (@Medical Specialties) experienced а -5.29% price change this week, while VMD (@Medical Specialties) price change was -2.39% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.22%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +1.33%.

Reported Earning Dates

ICAD is expected to report earnings on Feb 26, 2025.

VMD is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (-4.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VMD($364M) has a higher market cap than ICAD($42.4M). VMD YTD gains are higher at: 9.427 vs. ICAD (1.130). VMD has higher annual earnings (EBITDA): 36.7M vs. ICAD (-12.18M). ICAD has more cash in the bank: 19M vs. VMD (12.8M). ICAD has less debt than VMD: ICAD (514K) vs VMD (10.3M). VMD has higher revenues than ICAD: VMD (183M) vs ICAD (25.4M).
ICADVMDICAD / VMD
Capitalization42.4M364M12%
EBITDA-12.18M36.7M-33%
Gain YTD1.1309.42712%
P/E RatioN/A37.52-
Revenue25.4M183M14%
Total Cash19M12.8M148%
Total Debt514K10.3M5%
FUNDAMENTALS RATINGS
ICAD vs VMD: Fundamental Ratings
ICAD
VMD
OUTLOOK RATING
1..100
186
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9671
PRICE GROWTH RATING
1..100
4345
P/E GROWTH RATING
1..100
10060
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICAD's Valuation (34) in the Computer Peripherals industry is somewhat better than the same rating for VMD (67) in the null industry. This means that ICAD’s stock grew somewhat faster than VMD’s over the last 12 months.

VMD's Profit vs Risk Rating (68) in the null industry is in the same range as ICAD (100) in the Computer Peripherals industry. This means that VMD’s stock grew similarly to ICAD’s over the last 12 months.

VMD's SMR Rating (71) in the null industry is in the same range as ICAD (96) in the Computer Peripherals industry. This means that VMD’s stock grew similarly to ICAD’s over the last 12 months.

ICAD's Price Growth Rating (43) in the Computer Peripherals industry is in the same range as VMD (45) in the null industry. This means that ICAD’s stock grew similarly to VMD’s over the last 12 months.

VMD's P/E Growth Rating (60) in the null industry is somewhat better than the same rating for ICAD (100) in the Computer Peripherals industry. This means that VMD’s stock grew somewhat faster than ICAD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICADVMD
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
ICAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ICAD and

Correlation & Price change

A.I.dvisor tells us that ICAD and HYPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ICAD and HYPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICAD
1D Price
Change %
ICAD100%
-1.10%
HYPR - ICAD
29%
Poorly correlated
-2.09%
VMD - ICAD
29%
Poorly correlated
-1.15%
BAX - ICAD
27%
Poorly correlated
+0.75%
EW - ICAD
26%
Poorly correlated
+0.28%
STSS - ICAD
24%
Poorly correlated
-2.83%
More

VMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, VMD has been loosely correlated with ICUI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VMD jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VMD
1D Price
Change %
VMD100%
-1.15%
ICUI - VMD
40%
Loosely correlated
-1.19%
HBIO - VMD
38%
Loosely correlated
+1.40%
INMD - VMD
35%
Loosely correlated
-0.78%
AVNS - VMD
35%
Loosely correlated
-4.11%
RDNT - VMD
34%
Loosely correlated
-1.87%
More